Company / Total Debt
Boston Scientific Total Debt History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$3.8B
FY2017
5-year range
-
FY2016-FY2017
Trend
-29.6%
vs FY2016
Sector context
#25 of 100
Health Care
What the data says
Boston Scientific's total debt of $3.8B is higher than 75% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$3.8B in FY2017. Top quartile in the Health Care sector.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 100This company $3.8B Sector average $4.6B
▼
-16.2% below sector average
Key checks
Key Insights
- In FY2017, total debt decreased 29.6% year-over-year.
- Ranks #25 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $3.8B | -29.6% |
| FY2016 | $5.4B | -4.1% |
As of FY2017 · SEC 10-K · Updated Jul 2, 2026